Literature DB >> 11440191

Nitric oxide production by macrophages of dogs vaccinated with killed Leishmania infantum promastigotes.

M A Panaro1, A Acquafredda, S Lisi, D D Lofrumento, V Mitolo, M Sisto, A Fasanella, T Trotta, F Bertani, B Consenti, O Brandonisio.   

Abstract

Human visceral leishmaniosis is endemic in Southern Italy, where the dog is the main reservoir of viscerotropic strains of Leishmania infantum. The release of nitric oxide (NO) by interferon (IFN)-gamma-activated macrophages is an important leishmanicidal mechanism in several animal species. In this work NO production, phagocytosis and killing capacity of monocyte-derived dog macrophages were evaluated in vitro before and after administration of a vaccine composed of killed Leishmania infantum promastigotes. Moreover, IFN-gamma content was measured in concanavalin A-activated dog peripheral blood mononuclear cell (PBMC) supernatants employed for macrophage stimulation. Phagocytosis, killing capacity and NO production by canine macrophages increased significantly 1 month after vaccine administration, and the increase also persisted 5 months later. In addition, the amount of IFN-gamma in PBMC supernatants was significantly higher after vaccination. Overall, our results suggest the usefulness of evaluating the in vivo protective role of this promastigote preparation in dogs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440191     DOI: 10.1016/s0147-9571(00)00026-6

Source DB:  PubMed          Journal:  Comp Immunol Microbiol Infect Dis        ISSN: 0147-9571            Impact factor:   2.268


  16 in total

1.  Evaluation of Live Recombinant Nonpathogenic Leishmania tarentolae Expressing Cysteine Proteinase and A2 Genes as a Candidate Vaccine against Experimental Canine Visceral Leishmaniasis.

Authors:  Mehdi Shahbazi; Farnaz Zahedifard; Tahereh Taheri; Yasaman Taslimi; Shahram Jamshidi; Sadegh Shirian; Niousha Mahdavi; Mehdi Hassankhani; Yahya Daneshbod; Sayyed Hamid Zarkesh-Esfahani; Barbara Papadopoulou; Sima Rafati
Journal:  PLoS One       Date:  2015-07-21       Impact factor: 3.240

2.  LBSapSal-vaccinated dogs exhibit increased circulating T-lymphocyte subsets (CD4⁺ and CD8⁺) as well as a reduction of parasitism after challenge with Leishmania infantum plus salivary gland of Lutzomyia longipalpis.

Authors:  Rodrigo Dian de Oliveira Aguiar-Soares; Bruno Mendes Roatt; Henrique Gama Ker; Nádia das Dores Moreira; Fernando Augusto Siqueira Mathias; Jamille Mirelle de Oliveira Cardoso; Nelder Figueiredo Gontijo; Oscar Bruna-Romero; Andréa Teixeira-Carvalho; Olindo Assis Martins-Filho; Rodrigo Corrêa-Oliveira; Rodolfo Cordeiro Giunchetti; Alexandre Barbosa Reis
Journal:  Parasit Vectors       Date:  2014-02-07       Impact factor: 3.876

Review 3.  Animal models for the study of leishmaniasis immunology.

Authors:  Elsy Nalleli Loría-Cervera; Fernando José Andrade-Narváez
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2014 Jan-Feb       Impact factor: 1.846

4.  Impact of LbSapSal Vaccine in Canine Immunological and Parasitological Features before and after Leishmania chagasi-Challenge.

Authors:  Lucilene Aparecida Resende; Rodrigo Dian de Oliveira Aguiar-Soares; Henrique Gama-Ker; Bruno Mendes Roatt; Ludmila Zanandreis de Mendonça; Marina Luiza Rodrigues Alves; Denise da Silveira-Lemos; Rodrigo Corrêa-Oliveira; Olindo Assis Martins-Filho; Márcio Sobreira Silva Araújo; Ricardo Toshio Fujiwara; Nelder Figueiredo Gontijo; Alexandre Barbosa Reis; Rodolfo Cordeiro Giunchetti
Journal:  PLoS One       Date:  2016-08-24       Impact factor: 3.240

Review 5.  Biomarkers Associated With Leishmania infantum Exposure, Infection, and Disease in Dogs.

Authors:  Carla Maia; Lenea Campino
Journal:  Front Cell Infect Microbiol       Date:  2018-09-06       Impact factor: 5.293

6.  Performance of LBSap vaccine after intradermal challenge with L. infantum and saliva of Lu. longipalpis: immunogenicity and parasitological evaluation.

Authors:  Bruno Mendes Roatt; Rodrigo Dian de Oliveira Aguiar-Soares; Juliana Vitoriano-Souza; Wendel Coura-Vital; Samuel Leôncio Braga; Rodrigo Corrêa-Oliveira; Olindo Assis Martins-Filho; Andréa Teixeira-Carvalho; Marta de Lana; Nelder Figueiredo Gontijo; Marcos José Marques; Rodolfo Cordeiro Giunchetti; Alexandre Barbosa Reis
Journal:  PLoS One       Date:  2012-11-26       Impact factor: 3.240

7.  A review of adjuvants for Leishmania vaccine candidates.

Authors:  Joshua M Mutiso; John C Macharia; Michael M Gicheru
Journal:  J Biomed Res       Date:  2010-01

8.  Canine leishmaniasis in Southern Italy: a role for nitric oxide released from activated macrophages in asymptomatic infection?

Authors:  Maria A Panaro; Olga Brandonisio; Donato de Caprariis; Pasqua Cavallo; Antonia Cianciulli; Vincenzo Mitolo; Domenico Otranto
Journal:  Parasit Vectors       Date:  2008-05-09       Impact factor: 3.876

9.  Use of a recombinant cysteine proteinase from Leishmania (Leishmania) infantum chagasi for the Immunotherapy of canine visceral Leishmaniasis.

Authors:  Josie Haydée Lima Ferreira; Lucilene Dos Santos Silva; Ieda Maria Longo-Maugéri; Simone Katz; Clara Lúcia Barbiéri
Journal:  PLoS Negl Trop Dis       Date:  2014-03-13

10.  Kinetics of cell migration to the dermis and hypodermis in dogs vaccinated with antigenic compounds of Leishmania braziliensis plus saponin.

Authors:  Juliana Vitoriano-Souza; Alexandre B Reis; Nádia D Moreira; Rodolfo C Giunchetti; Rodrigo Correa-Oliveira; Cláudia M Carneiro
Journal:  Vaccine       Date:  2008-05-22       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.